DARIAN WALES: Open Payments
NPI 1447778998 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$469 in 21 payments from 9 companies in 2025. Trend: 2023 $590 · 2024 $396 · 2025 $469
Food & beverage: $469
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $216 |
| Sumitomo Pharma America, Inc. | 4 | $84 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $39 |
| ABBVIE INC. | 2 | $37 |
| Antares Pharma, Inc. | 1 | $26 |
| COLOPLAST CORP | 1 | $19 |
| Dendreon Pharmaceuticals LLC | 1 | $17 |
| Caris MPI, Inc. | 1 | $15 |
| PFIZER INC. | 1 | $14 |
Products named: ERLEADA, GEMTESA, JOURNAVX, BOTOX, ORGOVYX, XYOSTED, RYBREVANT, Titan.
Industry payments across TN — which companies pay providers there.
